Figure 1 (Margenza 01)
Margenza Injection, Solution, Concentrate
Product Images NDC 70720-022
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Margenza (NDC 70720-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tersera Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (250 mg/10 mL Vial Carton)
Contents: Each single-dose vial contains 250 mg of solution. The solution contains margeluximab ok, L-arginine hydrochloride, polysorbate 80, sodium chloride, sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate, sucrose, and Water for Injection, USP. The dosage details are available in the Prescribing Information. Margenza is an injection for intravenous infusion after dilution. It should be stored refrigerated between 2°C to 8°C and must not be frozen or shaken. This medication is not to be used if the vial is broken or missing. It does not contain preservatives.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
